Australian vaccine set for overseas test

The effectiveness of a University of Queensland vaccine for coronavirus is about to be tested in a biosecurity facility in the Netherlands.

The vaccine will be used on live coronavirus for the first time to determine how effectively it induces protection against infection.

UQ's vaccine program co-leader Dr Keith Chappell said the trial will establish a critical package of data ahead of human clinical trials later this year. Clinical studies will be conducted by Viroclinics Xplore which offers a myriad of preclinical tests including toxicology of drugs, antibodies, and antivirals targeting viral infectious diseases.

 

UQ created COVID-19 in its laboratory and then set about designing a vaccine to combat the virus.

The vaccine locks the "spike" protein into a shape which allows the immune system to be able to recognise and neutralise it.

UQ's Professor Trent Munro said beginning a large multi-arm study at Viroclinics Xplore was critical, before human testing, because it would establish a more comprehensive understanding of how the vaccine performs.

Originally published as UQ coronavirus vaccine set for overseas test



Police search finds drugs packed into bags, scales

Premium Content Police search finds drugs packed into bags, scales

Jademan Bounkham Drieberg wouldn’t hand over his phone because it would...

UPDATE: Toddler nearly drowns, trapped in ladder

Premium Content UPDATE: Toddler nearly drowns, trapped in ladder

Boy trapped after head was caught in a pool ladder

REVEALED: How Gladstone’s Mater will look under public care

Premium Content REVEALED: How Gladstone’s Mater will look under public care

WHEN work will be completed and what staff numbers will look like.